scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.NEURES.2007.10.002 |
P8608 | Fatcat ID | release_rkwngpyxdrhnvjeogrqzbmuso4 |
P698 | PubMed publication ID | 18022268 |
P50 | author | Francisco J Diaz-Corrales | Q43253747 |
P2093 | author name string | Norio Ogawa | |
Miho Murata | |||
Ikuko Miyazaki | |||
Ko Miyoshi | |||
Masato Asanuma | |||
P433 | issue | 1 | |
P921 | main subject | Parkinson's disease | Q11085 |
P304 | page(s) | 106-113 | |
P577 | publication date | 2007-10-10 | |
P1433 | published in | Neuroscience Research | Q15764280 |
P1476 | title | Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation | |
P478 | volume | 60 |
Q46130675 | A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice |
Q64779011 | Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications |
Q50266408 | Efficacy of zonisamide in a case of Parkinson's disease with intractable resting and re-emergent tremor |
Q35092165 | Medical management of Parkinson's disease: focus on neuroprotection |
Q37863681 | Motor complications, levodopa metabolism and progression of Parkinson's disease |
Q38684428 | Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs |
Q39076196 | Protective effects of zonisamide against rotenone-induced neurotoxicity |
Q49016618 | Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells |
Q33615756 | The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance |
Q42854732 | Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice |
Q43083221 | Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice |
Q37352050 | What's in the pipeline for the treatment of Parkinson's disease? |
Q37356891 | Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's disease |
Q45931490 | Zonisamide: in Parkinson's disease. |
Search more.